Holmes Scott A 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Aug 16, 2018
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-08-15$3.04/sh−1,185$3,602→ 165,365 total
Footnotes (2)
- [F1]Sale of a total of 1,185 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 4,063 shares of restricted stock on August 14, 2018. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 74,581 shares of restricted stock.